{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:19:36Z","timestamp":1790803176191,"version":"4.1.0"},"reference-count":86,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Airway infections are a key component of cystic fibrosis (CF) lung disease. Whereas the approach to common pathogens such as Pseudomonas aeruginosa is guided by a significant body of evidence, other infections often pose a considerable challenge to treating physicians. In Part I of this series on the antibiotic management of difficult lung infections, we discussed bacterial organisms including methicillin-resistant Staphylococcus aureus, gram-negative bacterial infections, and treatment of multiple bacterial pathogens. Here, we summarize the approach to infections with nontuberculous mycobacteria, anaerobic bacteria, and fungi. Nontuberculous mycobacteria can significantly impact the course of lung disease in patients with CF, but differentiation between colonization and infection is difficult clinically as coinfection with other micro-organisms is common. Treatment consists of different classes of antibiotics, varies in intensity, and is best guided by a team of specialized clinicians and microbiologists. The ability of anaerobic bacteria to contribute to CF lung disease is less clear, even though clinical relevance has been reported in individual patients. Anaerobes detected in CF sputum are often resistant to multiple drugs, and treatment has not yet been shown to positively affect patient outcome. Fungi have gained significant interest as potential CF pathogens. Although the role of Candida is largely unclear, there is mounting evidence that Scedosporium species and Aspergillus fumigatus, beyond the classical presentation of allergic bronchopulmonary aspergillosis, can be relevant in patients with CF and treatment should be considered. At present, however there remains limited information on how best to select patients who could benefit from antifungal therapy.<\/jats:p>","DOI":"10.1513\/annalsats.201405-203as","type":"journal-article","created":{"date-parts":[[2014,8,28]],"date-time":"2014-08-28T22:25:03Z","timestamp":1409264703000},"page":"1298-1306","source":"Crossref","is-referenced-by-count":79,"title":["Antibiotic Management of Lung Infections in Cystic Fibrosis. II. Nontuberculous Mycobacteria, Anaerobic Bacteria, and Fungi"],"prefix":"10.1093","volume":"11","author":[{"given":"James F.","family":"Chmiel","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Case Western Reserve University School of Medicine and Rainbow Babies and Children\u2019s Hospital, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.","family":"Aksamit","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Disease and Critical Care Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay H.","family":"Chotirmall","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Beaumont Hospital, Dublin, Republic of Ireland and Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elliott C.","family":"Dasenbrook","sequence":"additional","affiliation":[{"name":"Departments of Medicine and Pediatrics, Case Western Reserve University School of Medicine and University Hospitals Case Medical Center, Rainbow Babies and Children\u2019s Hospital, Cleveland, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Stuart","family":"Elborn","sequence":"additional","affiliation":[{"name":"Medicine and Surgery, Queens University Belfast and Belfast City Hospital, Belfast, Northern Ireland, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"LiPuma","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Communicable Diseases, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarath C.","family":"Ranganathan","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Royal Children\u2019s Hospital, Infection and Immunity Theme, Murdoch Children\u2019s Research Institute, and Department of Pediatrics, University of Melbourne, Melbourne, Australia; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie J.","family":"Waters","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix A.","family":"Ratjen","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Department of Pediatrics, University of Toronto and Hospital for Sick Children, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"2026012303512135800_bib1","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1164\/rccm.200505-840OE","article-title":"Cystic fibrosis since 1938","volume":"173","author":"Davis","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1465-9921-4-8","article-title":"State of the art: why do the lungs of patients with cystic fibrosis become infected and why can\u2019t they clear the infection?","volume":"4","author":"Chmiel","year":"2003","journal-title":"Respir Res"},{"key":"2026012303512135800_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jcf.2004.01.005","article-title":"Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults","volume":"3","author":"Courtney","year":"2004","journal-title":"J Cyst Fibros"},{"key":"2026012303512135800_bib4","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1164\/rccm.200802-327OC","article-title":"Persistent methicillin-resistant Staphylococcus aureus and rate of FEV1 decline in cystic fibrosis","volume":"178","author":"Dasenbrook","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib5","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/0895-4356(94)00230-N","article-title":"Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection","volume":"48","author":"Demko","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"2026012303512135800_bib6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1183\/09031936.00166412","article-title":"Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS Patient Registry","volume":"43","author":"Kerem","year":"2014","journal-title":"Eur Respir J"},{"key":"2026012303512135800_bib7","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1513\/AnnalsATS.201402-050AS","article-title":"LipPuma JJ, Ranganathan SC, Waters V, Ratjen F. Antibiotic management of lung infections in cystic fibrosis: the microbiome, MRSA, gram-negative bacteria, and multiple infections","volume":"11","author":"Chmiel","year":"2014","journal-title":"Ann Am Thorac Soc"},{"key":"2026012303512135800_bib8","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1055\/s-0033-1333567","article-title":"Update on the epidemiology of pulmonary nontuberculous mycobacterial infections","volume":"34","author":"Kendall","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012303512135800_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1164\/rccm.200604-571ST","article-title":"An official ATS\/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases","volume":"175","author":"Griffith","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib10","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1164\/rccm.200207-678OC","article-title":"Nontuberculous mycobacteria. I. Multicenter prevalence study in cystic fibrosis","volume":"167","author":"Olivier","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib11","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1128\/JCM.01257-09","article-title":"Multicenter study of prevalence of nontuberculous mycobacteria in patients with cystic fibrosis in France","volume":"47","author":"Roux","year":"2009","journal-title":"J Clin Microbiol"},{"key":"2026012303512135800_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcf.2009.12.001","article-title":"Chronic Mycobacterium abscessus infection and lung function decline in cystic fibrosis","volume":"9","author":"Esther","year":"2010","journal-title":"J Cyst Fibros"},{"key":"2026012303512135800_bib13","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1136\/thx.2005.049247","article-title":"Non-tuberculous mycobacteria in end stage cystic fibrosis: implications for lung transplantation","volume":"61","author":"Chalermskulrat","year":"2006","journal-title":"Thorax"},{"key":"2026012303512135800_bib14","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3201\/eid1703.101510","article-title":"Nontuberculous mycobacteria from household plumbing of patients with nontuberculous mycobacteria disease","volume":"17","author":"Falkinham","year":"2011","journal-title":"Emerg Infect Dis"},{"key":"2026012303512135800_bib15","doi-asserted-by":"crossref","first-page":"16393","DOI":"10.1073\/pnas.0908446106","article-title":"Opportunistic pathogens enriched in showerhead biofilms","volume":"106","author":"Feazel","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012303512135800_bib16","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1086\/519383","article-title":"The recovery of Mycobacterium avium-intracellulare complex (MAC) from the residential bathrooms of patients with pulmonary MAC","volume":"45","author":"Nishiuchi","year":"2007","journal-title":"Clin Infect Dis"},{"key":"2026012303512135800_bib17","doi-asserted-by":"crossref","first-page":"7602","DOI":"10.1128\/AEM.00930-06","article-title":"Relationships between Mycobacterium isolates from patients with pulmonary mycobacterial infection and potting soils","volume":"72","author":"De Groote","year":"2006","journal-title":"Appl Environ Microbiol"},{"key":"2026012303512135800_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1513\/AnnalsATS.201301-013FR","article-title":"Reducing human exposure to Mycobacterium avium","volume":"10","author":"Falkinham","year":"2013","journal-title":"Ann Am Thorac Soc"},{"key":"2026012303512135800_bib19","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1164\/rccm.200805-686OC","article-title":"Pulmonary nontuberculous mycobacterial disease: prospective study of a distinct preexisting syndrome","volume":"178","author":"Kim","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"2026012303512135800_bib20","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1086\/503485","article-title":"Infection control recommendations for patients with cystic fibrosis: microbiology, important pathogens, and infection control practices to prevent patient-to-patient transmission","volume":"24","author":"Saiman","year":"2003","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026012303512135800_bib21","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1164\/ajrccm.185.2.231","article-title":"Respiratory outbreak of Mycobacterium abscessus subspecies massiliense in a lung transplant and cystic fibrosis center","volume":"185","author":"Aitken","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib22","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/S0140-6736(13)60632-7","article-title":"Whole-genome sequencing to identify transmission of Mycobacterium abscessus between patients with cystic fibrosis: a retrospective cohort study","volume":"381","author":"Bryant","year":"2013","journal-title":"Lancet"},{"key":"2026012303512135800_bib23","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1001\/jama.2013.1937","article-title":"Effect of azithromycin maintenance treatment on infectious exacerbations among patients with non-cystic fibrosis bronchiectasis: the BAT randomized controlled trial","volume":"309","author":"Altenburg","year":"2013","journal-title":"JAMA"},{"key":"2026012303512135800_bib24","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1378\/chest.12-0628","article-title":"Effect of azithromycin on systemic markers of inflammation in patients with cystic fibrosis uninfected with Pseudomonas aeruginosa","volume":"142","author":"Ratjen","year":"2012","journal-title":"Chest"},{"key":"2026012303512135800_bib25","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1001\/jama.2013.2290","article-title":"Effect of long-term, low-dose erythromycin on pulmonary exacerbations among patients with non-cystic fibrosis bronchiectasis: the BLESS randomized controlled trial","volume":"309","author":"Serisier","year":"2013","journal-title":"JAMA"},{"key":"2026012303512135800_bib26","first-page":"CD002203","article-title":"Macrolide antibiotics for cystic fibrosis","volume":"11","author":"Southern","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012303512135800_bib27","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/S0140-6736(12)60953-2","article-title":"Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial","volume":"380","author":"Wong","year":"2012","journal-title":"Lancet"},{"key":"2026012303512135800_bib28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1164\/rccm.201207-1160OE","article-title":"Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health","volume":"187","author":"Mogayzel","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib29","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1164\/rccm.201307-1200OC","article-title":"Epidemiology of nontuberculous mycobacterial infections and associated chronic macrolide use among persons with cystic fibrosis","volume":"188","author":"Binder","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib30","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2466-7-2","article-title":"Aerosolized amikacin for treatment of pulmonary Mycobacterium avium infections: an observational case series","volume":"7","author":"Davis","year":"2007","journal-title":"BMC Pulm Med"},{"key":"2026012303512135800_bib31","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1002\/ppul.21222","article-title":"Aerosolized amikacin and oral clarithromycin to eradicate Mycobacterium abscessus in a patient with cystic fibrosis: an 8-year follow-up","volume":"45","author":"Colin","year":"2010","journal-title":"Pediatr Pulmonol"},{"key":"2026012303512135800_bib32","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-0033-1333574","article-title":"Nontuberculous mycobacteria in patients with cystic fibrosis","volume":"34","author":"Leung","year":"2013","journal-title":"Semin Respir Crit Care Med"},{"key":"2026012303512135800_bib33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1128\/AAC.01275-08","article-title":"A novel gene, erm(41), confers inducible macrolide resistance to clinical isolates of Mycobacterium abscessus but is absent from Mycobacterium chelonae","volume":"53","author":"Nash","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303512135800_bib34","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","article-title":"Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance","volume":"186","author":"Choi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1164\/rccm.201003-0395OC","article-title":"Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus","volume":"183","author":"Koh","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.drup.2012.04.001","article-title":"Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria","volume":"15","author":"van Ingen","year":"2012","journal-title":"Drug Resist Updat"},{"key":"2026012303512135800_bib37","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1172\/JCI0213870","article-title":"Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients","volume":"109","author":"Worlitzsch","year":"2002","journal-title":"J Clin Invest"},{"key":"2026012303512135800_bib38","doi-asserted-by":"crossref","first-page":"e2908","DOI":"10.1371\/journal.pone.0002908","article-title":"Molecular detection of multiple emerging pathogens in sputa from cystic fibrosis patients","volume":"3","author":"Bittar","year":"2008","journal-title":"PLoS One"},{"key":"2026012303512135800_bib39","first-page":"51","article-title":"Transtracheal aspiration in pulmonary infection in children with cystic fibrosis","volume":"64","author":"Brook","year":"1983","journal-title":"Eur J Respir Dis"},{"key":"2026012303512135800_bib40","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1099\/00222615-31-4-271","article-title":"The incidence of anaerobes in the sputum of patients with cystic fibrosis","volume":"31","author":"Jewes","year":"1990","journal-title":"J Med Microbiol"},{"key":"2026012303512135800_bib41","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S0022-3476(84)81094-X","article-title":"Cultures of thoracotomy specimens confirm usefulness of sputum cultures in cystic fibrosis","volume":"104","author":"Thomassen","year":"1984","journal-title":"J Pediatr"},{"key":"2026012303512135800_bib42","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1164\/rccm.200708-1151OC","article-title":"Detection of anaerobic bacteria in high numbers in sputum from patients with cystic fibrosis","volume":"177","author":"Tunney","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib43","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/j.1469-0691.2008.02659.x","article-title":"Antibiotic-resistant obligate anaerobes during exacerbations of cystic fibrosis patients","volume":"15","author":"Worlitzsch","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"2026012303512135800_bib44","first-page":"185","article-title":"Anaerobic bacteria infection in cystic fibrosis airway disease","volume":"33","author":"Lambiase","year":"2010","journal-title":"New Microbiol"},{"key":"2026012303512135800_bib45","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1128\/JCM.02282-05","article-title":"Use of 16S rRNA gene profiling by terminal restriction fragment length polymorphism analysis to compare bacterial communities in sputum and mouthwash samples from patients with cystic fibrosis","volume":"44","author":"Rogers","year":"2006","journal-title":"J Clin Microbiol"},{"key":"2026012303512135800_bib46","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/cid\/cir399","article-title":"Inflammatory responses to individual microorganisms in the lungs of children with cystic fibrosis","volume":"53","author":"Gangell","year":"2011","journal-title":"Clin Infect Dis"},{"key":"2026012303512135800_bib47","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1164\/ajrccm.178.9.994","article-title":"Anaerobic bacterial infection in patients with cystic fibrosis","volume":"178","author":"Tai","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib48","doi-asserted-by":"crossref","first-page":"15070","DOI":"10.1073\/pnas.0804326105","article-title":"A polymicrobial perspective of pulmonary infections exposes an enigmatic pathogen in cystic fibrosis patients","volume":"105","author":"Sibley","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"2026012303512135800_bib49","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1136\/thx.2010.137745","article-title":"Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis","volume":"65","author":"Ulrich","year":"2010","journal-title":"Thorax"},{"key":"2026012303512135800_bib50","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1136\/thx.2010.137281","article-title":"Use of culture and molecular analysis to determine the effect of antibiotic treatment on microbial community diversity and abundance during exacerbation in patients with cystic fibrosis","volume":"66","author":"Tunney","year":"2011","journal-title":"Thorax"},{"key":"2026012303512135800_bib51","doi-asserted-by":"crossref","first-page":"e36313","DOI":"10.1371\/journal.pone.0036313","article-title":"The airway microbiota in cystic fibrosis: a complex fungal and bacterial community\u2014implications for therapeutic management","volume":"7","author":"Delhaes","year":"2012","journal-title":"PLoS One"},{"key":"2026012303512135800_bib52","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0140-6736(90)91721-L","article-title":"Exophiala dermatitidis infection in cystic fibrosis","volume":"336","author":"Haase","year":"1990","journal-title":"Lancet"},{"key":"2026012303512135800_bib53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/j.1439-0507.1991.tb00797.x","article-title":"Long-term fungal cultures from sputum of patients with cystic fibrosis","volume":"34","author":"Haase","year":"1991","journal-title":"Mycoses"},{"key":"2026012303512135800_bib54","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1159\/000079640","article-title":"Isolation of fungi, especially Exophiala dermatitidis, in patients suffering from cystic fibrosis: a prospective study","volume":"71","author":"Horr\u00e9","year":"2004","journal-title":"Respiration"},{"key":"2026012303512135800_bib55","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF02113255","article-title":"Exophiala dermatitidis pneumonia in cystic fibrosis","volume":"151","author":"Kusenbach","year":"1992","journal-title":"Eur J Pediatr"},{"key":"2026012303512135800_bib56","first-page":"89","article-title":"[Detection of Exophiala dermatitidis (Kano) De Hoog 1977 in septicemia of a child with acute lymphatic leukemia and in patients with cystic fibrosis]","volume":"37","author":"Blaschke-Hellmessen","year":"1994","journal-title":"Mycoses"},{"key":"2026012303512135800_bib57","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/JCM.01899-10","article-title":"High rate of Exophiala dermatitidis recovery in the airways of patients with cystic fibrosis is associated with pancreatic insufficiency","volume":"49","author":"Kondori","year":"2011","journal-title":"J Clin Microbiol"},{"key":"2026012303512135800_bib58","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2217\/fmb.13.63","article-title":"Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance","volume":"8","author":"Giraud","year":"2013","journal-title":"Future Microbiol"},{"key":"2026012303512135800_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/723129","article-title":"Aspergillus-associated airway disease, inflammation, and the innate immune response","author":"Chotirmall","year":"2013","journal-title":"Biomed Res Int"},{"key":"2026012303512135800_bib60","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.biocel.2014.03.001","article-title":"Fungi in the cystic fibrosis lung: bystanders or pathogens?","volume":"52","author":"Chotirmall","year":"2014","journal-title":"Int J Biochem Cell Biol"},{"key":"2026012303512135800_bib61","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1378\/chest.09-2996","article-title":"Sputum Candida albicans presages FEV\u2081 decline and hospital-treated exacerbations in cystic fibrosis","volume":"138","author":"Chotirmall","year":"2010","journal-title":"Chest"},{"key":"2026012303512135800_bib62","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.3109\/13693786.2010.503320","article-title":"Candida species in cystic fibrosis: a road less travelled","volume":"48","author":"Chotirmall","year":"2010","journal-title":"Med Mycol"},{"key":"2026012303512135800_bib63","first-page":"1035","article-title":"Aspergillus\/allergic bronchopulmonary aspergillosis in an Irish cystic fibrosis population: a diagnostically challenging entity","volume":"53","author":"Chotirmall","year":"2008","journal-title":"Respir Care"},{"key":"2026012303512135800_bib64","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1086\/376525","article-title":"Allergic bronchopulmonary aspergillosis in cystic fibrosis\u2014state of the art: Cystic Fibrosis Foundation Consensus Conference","volume":"37","author":"Stevens","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026012303512135800_bib65","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jcf.2012.04.008","article-title":"Blood basophils from cystic fibrosis patients with allergic bronchopulmonary aspergillosis are primed and hyper-responsive to stimulation by Aspergillus allergens","volume":"11","author":"Gernez","year":"2012","journal-title":"J Cyst Fibros"},{"key":"2026012303512135800_bib66","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jcf.2009.04.008","article-title":"Intravenous monthly pulse methylprednisolone treatment for ABPA in patients with cystic fibrosis","volume":"8","author":"Cohen-Cymberknoh","year":"2009","journal-title":"J Cyst Fibros"},{"key":"2026012303512135800_bib67","first-page":"CD002204","article-title":"Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis","volume":"6","author":"Elphick","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"2026012303512135800_bib68","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1128\/AAC.05077-11","article-title":"High prevalence of azole-resistant Aspergillus fumigatus in adults with cystic fibrosis exposed to itraconazole","volume":"56","author":"Burgel","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026012303512135800_bib69","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1183\/09031936.00097611","article-title":"High frequency of voriconazole-related phototoxicity in cystic fibrosis patients","volume":"39","author":"Rondeau","year":"2012","journal-title":"Eur Respir J"},{"key":"2026012303512135800_bib70","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.22937","article-title":"Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence","volume":"49","author":"Tanou","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"2026012303512135800_bib71","doi-asserted-by":"crossref","first-page":"842","DOI":"10.3109\/00365548.2012.695454","article-title":"Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients","volume":"44","author":"Fillaux","year":"2012","journal-title":"Scand J Infect Dis"},{"key":"2026012303512135800_bib72","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1378\/chest.12-1363","article-title":"IgE-mediated immune responses and airway detection of Aspergillus and Candida in adult cystic fibrosis","volume":"143","author":"Baxter","year":"2013","journal-title":"Chest"},{"key":"2026012303512135800_bib73","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/INF.0000000000000231","article-title":"Aspergillus sensitization or carriage in cystic fibrosis patients","volume":"33","author":"Fillaux","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"2026012303512135800_bib74","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jaci.2013.04.007","article-title":"Novel immunologic classification of aspergillosis in adult cystic fibrosis","volume":"132","author":"Baxter","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"2026012303512135800_bib75","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1378\/chest.09-1103","article-title":"The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis","volume":"137","author":"Amin","year":"2010","journal-title":"Chest"},{"key":"2026012303512135800_bib76","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1016\/j.ejrad.2011.01.114","article-title":"Radiological abnormalities associated with Aspergillus colonization in a cystic fibrosis population","volume":"81","author":"McMahon","year":"2012","journal-title":"Eur J Radiol"},{"key":"2026012303512135800_bib77","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1164\/rccm.201203-0478OC","article-title":"The effect of Aspergillus fumigatus infection on vitamin D receptor expression in cystic fibrosis","volume":"186","author":"Coughlan","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026012303512135800_bib78","doi-asserted-by":"crossref","first-page":"e36077","DOI":"10.1371\/journal.pone.0036077","article-title":"Treatment of Aspergillus fumigatus in patients with cystic fibrosis: a randomized, placebo-controlled pilot study","volume":"7","author":"Aaron","year":"2012","journal-title":"PLoS One"},{"key":"2026012303512135800_bib79","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11845-010-0488-0","article-title":"Thrombolysis for indwelling catheter related thrombosis and superior vena cava obstruction in cystic fibrosis: a case series","volume":"179","author":"Hassan","year":"2010","journal-title":"Ir J Med Sci"},{"key":"2026012303512135800_bib80","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s100960050011","article-title":"Clinical significance of Scedosporium apiospermum in patients with cystic fibrosis","volume":"19","author":"Cimon","year":"2000","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2026012303512135800_bib81","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1128\/JCM.39.1.47-50.2001","article-title":"Molecular epidemiology of Scedosporium apiospermum infection determined by PCR amplification of ribosomal intergenic spacer sequences in patients with chronic lung disease","volume":"39","author":"Williamson","year":"2001","journal-title":"J Clin Microbiol"},{"key":"2026012303512135800_bib82","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1080\/13693780802627440","article-title":"A review of German Scedosporium prolificans cases from 1993 to 2007","volume":"47","author":"Tintelnot","year":"2009","journal-title":"Med Mycol"},{"key":"2026012303512135800_bib83","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00436921","article-title":"Potted plants in hospitals as reservoirs of pathogenic fungi","volume":"106","author":"Summerbell","year":"1989","journal-title":"Mycopathologia"},{"key":"2026012303512135800_bib84","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.3109\/13693786.2010.500627","article-title":"Clinical associations and prevalence of Scedosporium spp. in Australian cystic fibrosis patients: identification of novel risk factors?","volume":"48","author":"Blyth","year":"2010","journal-title":"Med Mycol"},{"key":"2026012303512135800_bib85","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1128\/JCM.40.6.2108-2114.2002","article-title":"Genotyping study of Scedosporium apiospermum isolates from patients with cystic fibrosis","volume":"40","author":"Defontaine","year":"2002","journal-title":"J Clin Microbiol"},{"key":"2026012303512135800_bib86","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/13693780600752507","article-title":"Scedosporium apiospermum: changing clinical spectrum of a therapy-refractory opportunist","volume":"44","author":"Guarro","year":"2006","journal-title":"Med Mycol"}],"container-title":["Annals of the American Thoracic Society"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/11\/8\/1298\/66552043\/annalsats_11_8_1298.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annalsats\/article-pdf\/11\/8\/1298\/66552043\/annalsats_11_8_1298.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T08:51:37Z","timestamp":1769158297000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annalsats\/article\/11\/8\/1298\/8431889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2014,10,1]]},"published-print":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.1513\/annalsats.201405-203as","relation":{},"ISSN":["2329-6933","2325-6621"],"issn-type":[{"value":"2329-6933","type":"print"},{"value":"2325-6621","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2014,10]]},"published":{"date-parts":[[2014,10,1]]}}}